[{"NetIncomeLoss_1_Q2_USD":-22937000.0,"OperatingLeaseLiability_0_Q2_USD":3002000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":11.83,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":12169000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":120000.0,"RoyaltyExpense_2_Q2_USD":210000.0,"RoyaltyExpense_1_Q2_USD":210000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-13000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":85272000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":61569000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":209000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q2_shares":209000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":513000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":78000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":64000.0,"AssetsCurrent_0_Q2_USD":249369000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":25445000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":13475000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":293000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":200000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":1427850.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":131000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":539000.0,"UnrecognizedTaxBenefits_0_Q2_USD":0.0,"CommonStockSharesIssued_0_Q2_shares":43576950.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":3700000.0,"Assets_0_Q2_USD":259479000.0,"ShareBasedCompensation_2_Q2_USD":9525000.0,"Liabilities_0_Q2_USD":25163000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":3398000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":988000.0,"OtherAssetsNoncurrent_0_Q2_USD":4793000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":41357000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":19778000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":23.1,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":3278000.0,"EarningsPerShareBasic_2_Q2_USD":0.25,"EarningsPerShareBasic_1_Q2_USD":-0.53,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":35000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":45080419.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":43569482.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-563000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-225000.0,"AccountsReceivableNetCurrent_0_Q2_USD":8517000.0,"CommonStockValue_0_Q2_USD":4000.0,"IncreaseDecreaseInOtherCurrentAssets_2_Q2_USD":-4284000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":346000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":-513000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":107966000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q2_USD":4827000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q2_USD":0.0,"CostsAndExpenses_2_Q2_USD":67305000.0,"CostsAndExpenses_1_Q2_USD":33663000.0,"OtherAssetsCurrent_0_Q2_USD":3445000.0,"IncreaseDecreaseInInventories_2_Q2_USD":3820000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":10476000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-22937000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":10989000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-22859000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-2569000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":233587000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":1503000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":36.95,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":107725000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":118953000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":8517000.0,"EarningsPerShareDiluted_2_Q2_USD":0.23,"EarningsPerShareDiluted_1_Q2_USD":-0.53,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":10476000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-22937000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":78000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-50617000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":42724813.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":43569482.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":1589000.0,"LiabilitiesCurrent_0_Q2_USD":20986000.0,"AccountsPayableCurrent_0_Q2_USD":6803000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":233587000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":241000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":998000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.076,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":10476000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":-22937000.0,"AdditionalPaidInCapital_0_Q2_USD":509049000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":74332.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"OperatingLeasePayments_2_Q2_USD":1093000.0,"OperatingLeasePayments_1_Q2_USD":549000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"DividendsCommonStock_2_Q2_USD":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":76242000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1919000.0,"NetIncomeLoss_2_Q2_USD":10476000.0,"CurrentIncomeTaxExpenseBenefit_1_Q2_USD":0.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CurrentIncomeTaxExpenseBenefit_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":3370715.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":32.44,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":32.44,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":276000.0,"ProceedsFromSaleOfProductiveAssets_2_Q2_USD":62010000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":16334000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":10951000.0,"OperatingIncomeLoss_2_Q2_USD":-50971000.0,"OperatingIncomeLoss_1_Q2_USD":-22712000.0,"InventoryNet_0_Q2_USD":3820000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":32.44,"PreferredStockValue_0_Q2_USD":null,"DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_2_Q2_USD":62010000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":0.0,"DeferredIncomeTaxExpenseBenefit_1_Q2_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":3.24,"OperatingLeaseCost_2_Q2_USD":1291000.0,"OperatingLeaseCost_1_Q2_USD":646000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":259479000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5500000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":25000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2014000.0,"ProfitLoss_2_Q2_USD":10476000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":939000.0,"StockholdersEquity_0_Q2_USD":234316000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":441000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":5783768.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-274724000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1086000.0,"Ticker":"YMAB","CIK":"1722964","name":"Y-MABS THERAPEUTICS, INC.","OfficialName":"Y-mAbs Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"556910423.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]